U.S. stock night trading opens with fluctuations: Mastec drops 14.08% in night trading; Roblox drops 13.85% in night trading

U.S. Stock Night Market Opening Movements

Mastec fell 14.08% in the night market. Based on recent key news:

1. On July 31, MasTec announced its second-quarter financial report, showing a 23% revenue growth and a 40% increase in adjusted EBITDA, but the market was disappointed with its full-year outlook, leading to a drop in stock price. The company expects full-year revenue of $18.2 billion and operating cash flow exceeding $1 billion. Source: MasTec, Inc.

2. On July 30, MasTec announced that Alex Spiro joined the board as a Class III director. Spiro has extensive experience in corporate governance and securities matters, but this news failed to boost the stock price. Source: Business Wire

3. On July 29, MasTec's core business continued to grow strongly, with global module shipments reaching 61.9GW, but the market remains cautious about its future growth, affecting stock performance. Source: MasTec, Inc.

Roblox fell 13.85% in the night market. Based on recent key news:

1. On July 31, Roblox announced its second-quarter results, with key metrics falling short of analyst expectations, and third-quarter booking guidance significantly below Wall Street expectations, causing the stock price to plummet by 11.5%. The company reported a loss of $0.26 per share, with daily active users reaching 123 million, below the market expectation of 128.71 million. Bookings were reported at $1.56 billion, lower than the market estimate of $1.6 billion. Source: Investing.com

2. On July 30, Roblox forecasted a significant decline in third-quarter bookings due to adjustments in its recommendation algorithm leading young users to shift towards lower-spending games, causing the stock price to drop 14% in after-hours trading. Source: Reuters

3. On July 30, the European Union announced that Roblox would be subject to the strictest platform regulations, further exacerbating market concerns. Source: Bloomberg News The overall performance of the gaming industry is weak, with increasing macroeconomic pressures and unstable capital flows.

Top Gainers in the U.S. Stock Night Market

Replimune rose 134.75% in the night market. Based on recent key news:

1. On July 30, Replimune announced favorable results from the FDA Cellular, Tissue, and Gene Therapies Advisory Committee meeting, supporting the efficacy of RP1 in advanced melanoma. This news significantly boosted the stock price.

2. On July 28, FDA reviewers expressed concerns about Replimune's RP1 drug trial, stating that the trial data was insufficient to prove the drug's efficacy. This news led to a significant drop in stock price during pre-market trading.

3. On July 29, Replimune fell 33.26% during the day, as FDA review documents indicated that RP1 faces regulatory challenges, with BMO analysts noting concerns about the drug's component contributions and the heterogeneity of the treatment population. The FDA review results drove the stock price up, but regulatory challenges remain AXT Company rose 22.82% in after-hours trading. Based on recent key news:

4. On July 30, AXT announced a long-term supply agreement with Lumentum to ensure the supply of indium phosphide wafer substrates in the future. Lumentum will pay a total of $87 million in advance to secure the supply of indium phosphide wafers until 2031. This agreement significantly boosted market confidence in AXT's future performance, driving the stock price up.

5. On July 30, AXT released its second-quarter financial report, with adjusted net income of $0.19 per share, far exceeding analysts' expectations of $0.07. Quarterly revenue grew to $47.6 million, a substantial increase from $18 million in the same period last year. The strong financial performance further lifted the stock price.

6. On July 30, AXT CEO Morris Young stated that the company's business has reached a turning point, with strong demand for data center optical connections, coupled with improved manufacturing capacity and productivity, driving significant revenue growth. This statement enhanced investor confidence in the company's future development, propelling the stock price upward. The demand in the compound semiconductor industry is strong, with AI data center expansions driving increased demand for indium phosphide.

Kioxia Semiconductor rose 20.56% in after-hours trading. Based on recent key news:

1. On July 30, Kioxia Semiconductor released its second-quarter financial report, with revenue growing 38% year-over-year to $149 million, and improvements in gross margin and adjusted EBITDA. The outlook for the third quarter is strong, with expected revenue growth of 14% quarter-over-quarter and 35% year-over-year, primarily driven by demand for high-performance computing. This news significantly boosted the stock price.

2. On July 29, Wall Street analysts held an optimistic view on Kioxia Semiconductor's future performance, expecting nearly 50% upside potential for the stock price, and gave seven buy ratings, with only one hold and one sell rating. The analysts' positive evaluations further boosted market confidence.

3. On July 30, Kioxia Semiconductor reported a second-quarter earnings per share of $0, with operating revenue of $292,000 and a net income of -$200,000. Despite the negative net income, the expected sales for the third quarter are $170 million, higher than the market expectation of $146.3 million, indicating the company's future growth potential. Demand for high-performance computing is strong, and the industry outlook is optimistic